Clinical Data Mulls Spinning Off Genetic Test Business; Files $200M Shelf Registration | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Clinical Data is considering selling off its genetic testing and biomarker development business, including its CLIA lab, according to a filing with the US Securities and Exchange Commission.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.